Chemicals called PFAS may lower bone density in adolescents, a new study has found.

Cell- and animal-based models of bone formation reveal novel mechanisms involved in the cartilage-to-bone phenotype ...

Exposure to “forever chemicals” early in life may quietly shape how strong a child’s bones become later on. New research ...

Early-life exposure to per- and polyfluoroalkyl substances (PFAS) may influence how children's bones develop during adolescence, according to new research published in the Journal of the Endocrine ...

Early-life exposure to per- and polyfluoroalkyl substances (PFAS) may influence how children's bones develop during adolescence, according to new research published in the Journal of the Endocrine ...

A new paper published in Osteoporosis International describes the rigorous, user-centered development of "Build Better Bones, ...

Serial PFAS biomonitoring at delivery and ages 3, 8, and 12 enabled assessment of exposure windows against DXA-derived BMD at six skeletal sites at age 12. PFOA showed the most consistent signal, with ...

Exposure to per- and polyfluoroalkyl substances (PFAS) in early life may influence bone development during adolescence, according a study published online March 17 in the Journal of the Endocrine ...

Design and characterization of piezoelectrically and topographically originated biomimetic scaffolds. (a) Schematic representation of the enhanced bone regeneration mechanism through electrical and ...

This is a rare peek at how cartilage transforms into bone. In this image, you can see cartilage (in purple and white), blood vessels and cells (in yellow), and other specialized cells that create ...

Scientists have identified a protein that blocks the activity of bone-forming cells (osteoblasts) by stopping them from maturing during the journey to sites of bone formation, a new study has found.

March 16 (Reuters) - BioMarin Pharmaceutical will discontinue mid-stage trials of its bone disorder treatment after reports of several cases of patients' hip joint slipping out of place, the drugmaker ...